m6A Target Gene Information
General Information of the m6A Target Gene (ID: M6ATAR00261)
Full List of m6A Methylation Regulator of This Target Gene and Corresponding Disease/Drug Response(s)
FSCN1
can be regulated by the following regulator(s), and cause disease/drug response(s). You can browse detail information of regulator(s) or disease/drug response(s).
Browse Regulator
Browse Disease
Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2BP1) [READER]
Representative RNA-seq result indicating the expression of this target gene regulated by IGF2BP1 | ||
Cell Line | HepG2 cell line | Homo sapiens |
Treatment: siIGF2BP1 HepG2 cells
Control: siControl HepG2 cells
|
GSE161086 | |
Regulation |
|
logFC: 9.48E-01 p-value: 8.70E-06 |
More Results | Click to View More RNA-seq Results |
In total 1 item(s) under this regulator | ||||
Experiment 1 Reporting the m6A Methylation Regulator of This Target Gene | [1] | |||
Response Summary | In contrast to the mRNA-decay-promoting function of YTH domain-containing family protein 2, IGF2BPs promote the stability and storage of their target mRNAs (for example, MYC) in an m6A-dependent manner under normal and stress conditions and therefore affect gene expression output. Four representative high confidence targets, including MYC, Fascin (FSCN1), TK1, and MARCKSL1, exhibit strong binding with IGF2BPs around their m6A motifs in control cells. Knocking down of each individual IGF2BPs in Hela (cervical cancer) and HepG2 (liver cancer) cells significantly repressed MYC expression. | |||
Responsed Disease | Hepatocellular carcinoma | ICD-11: 2C12.02 | ||
Cell Process | RNA decay | |||
In-vitro Model | Hep-G2 | Hepatoblastoma | Homo sapiens | CVCL_0027 |
HEK293T | Normal | Homo sapiens | CVCL_0063 | |
HeLa | Endocervical adenocarcinoma | Homo sapiens | CVCL_0030 | |
Hep-G2 | Hepatoblastoma | Homo sapiens | CVCL_0027 | |
Insulin-like growth factor 2 mRNA-binding protein 2 (IGF2BP2) [READER]
In total 1 item(s) under this regulator | ||||
Experiment 1 Reporting the m6A Methylation Regulator of This Target Gene | [1] | |||
Response Summary | In contrast to the mRNA-decay-promoting function of YTH domain-containing family protein 2, IGF2BPs promote the stability and storage of their target mRNAs (for example, MYC) in an m6A-dependent manner under normal and stress conditions and therefore affect gene expression output. Four representative high confidence targets, including MYC, Fascin (FSCN1), TK1, and MARCKSL1, exhibit strong binding with IGF2BPs around their m6A motifs in control cells. Knocking down of each individual IGF2BPs in Hela (cervical cancer) and HepG2 (liver cancer) cells significantly repressed MYC expression. | |||
Responsed Disease | Hepatocellular carcinoma | ICD-11: 2C12.02 | ||
Cell Process | RNA decay | |||
In-vitro Model | Hep-G2 | Hepatoblastoma | Homo sapiens | CVCL_0027 |
HEK293T | Normal | Homo sapiens | CVCL_0063 | |
HeLa | Endocervical adenocarcinoma | Homo sapiens | CVCL_0030 | |
Hep-G2 | Hepatoblastoma | Homo sapiens | CVCL_0027 | |
Insulin-like growth factor 2 mRNA-binding protein 3 (IGF2BP3) [READER]
In total 1 item(s) under this regulator | ||||
Experiment 1 Reporting the m6A Methylation Regulator of This Target Gene | [1] | |||
Response Summary | In contrast to the mRNA-decay-promoting function of YTH domain-containing family protein 2, IGF2BPs promote the stability and storage of their target mRNAs (for example, MYC) in an m6A-dependent manner under normal and stress conditions and therefore affect gene expression output. Four representative high confidence targets, including MYC, Fascin (FSCN1), TK1, and MARCKSL1, exhibit strong binding with IGF2BPs around their m6A motifs in control cells. Knocking down of each individual IGF2BPs in Hela (cervical cancer) and HepG2 (liver cancer) cells significantly repressed MYC expression. | |||
Responsed Disease | Hepatocellular carcinoma | ICD-11: 2C12.02 | ||
Cell Process | RNA decay | |||
In-vitro Model | Hep-G2 | Hepatoblastoma | Homo sapiens | CVCL_0027 |
HEK293T | Normal | Homo sapiens | CVCL_0063 | |
HeLa | Endocervical adenocarcinoma | Homo sapiens | CVCL_0030 | |
Hep-G2 | Hepatoblastoma | Homo sapiens | CVCL_0027 | |
Liver cancer [ICD-11: 2C12]
In total 1 item(s) under this disease | ||||
Experiment 1 Reporting the m6A-centered Disease Response | [1] | |||
Response Summary | In contrast to the mRNA-decay-promoting function of YTH domain-containing family protein 2, IGF2BPs promote the stability and storage of their target mRNAs (for example, MYC) in an m6A-dependent manner under normal and stress conditions and therefore affect gene expression output. Four representative high confidence targets, including MYC, Fascin (FSCN1), TK1, and MARCKSL1, exhibit strong binding with IGF2BPs around their m6A motifs in control cells. Knocking down of each individual IGF2BPs in Hela (cervical cancer) and HepG2 (liver cancer) cells significantly repressed MYC expression. | |||
Responsed Disease | Hepatocellular carcinoma [ICD-11: 2C12.02] | |||
Target Regulator | Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2BP1) | READER | ||
Cell Process | RNA decay | |||
In-vitro Model | Hep-G2 | Hepatoblastoma | Homo sapiens | CVCL_0027 |
HEK293T | Normal | Homo sapiens | CVCL_0063 | |
HeLa | Endocervical adenocarcinoma | Homo sapiens | CVCL_0030 | |
Hep-G2 | Hepatoblastoma | Homo sapiens | CVCL_0027 | |
Cervical cancer [ICD-11: 2C77]
In total 1 item(s) under this disease | ||||
Experiment 1 Reporting the m6A-centered Disease Response | [1] | |||
Response Summary | In contrast to the mRNA-decay-promoting function of YTH domain-containing family protein 2, IGF2BPs promote the stability and storage of their target mRNAs (for example, MYC) in an m6A-dependent manner under normal and stress conditions and therefore affect gene expression output. Four representative high confidence targets, including MYC, Fascin (FSCN1), TK1, and MARCKSL1, exhibit strong binding with IGF2BPs around their m6A motifs in control cells. Knocking down of each individual IGF2BPs in Hela (cervical cancer) and HepG2 (liver cancer) cells significantly repressed MYC expression. | |||
Responsed Disease | Cervical cancer [ICD-11: 2C77] | |||
Target Regulator | Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2BP1) | READER | ||
Cell Process | RNA decay | |||
In-vitro Model | Hep-G2 | Hepatoblastoma | Homo sapiens | CVCL_0027 |
HEK293T | Normal | Homo sapiens | CVCL_0063 | |
HeLa | Endocervical adenocarcinoma | Homo sapiens | CVCL_0030 | |
Hep-G2 | Hepatoblastoma | Homo sapiens | CVCL_0027 | |